Latest Insider Transactions at Willis Towers Watson PLC (WTW)
This section provides a real-time view of insider transactions for Willis Towers Watson PLC (WTW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of WILLIS TOWERS WATSON PLC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of WILLIS TOWERS WATSON PLC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 06
2023
|
Imran Ahmed Qureshi Head of North America |
SELL
Payment of exercise price or tax liability
|
Direct |
371
-4.85%
|
$86,072
$232.38 P/Share
|
|
Apr 06
2023
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Payment of exercise price or tax liability
|
Direct |
89
-0.11%
|
$20,648
$232.38 P/Share
|
|
Apr 06
2023
|
Pamela Thomson Hall Head of International |
SELL
Payment of exercise price or tax liability
|
Direct |
373
-4.71%
|
$86,536
$232.38 P/Share
|
|
Apr 06
2023
|
Joseph Stephen Kurpis PAO and Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-7.51%
|
$29,000
$232.38 P/Share
|
|
Apr 06
2023
|
Anne Pullum Head of Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
176
-0.98%
|
$40,832
$232.38 P/Share
|
|
Apr 03
2023
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
2,500
-2.95%
|
$580,000
$232.38 P/Share
|
|
Apr 01
2023
|
Anne Pullum Head of Europe |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
4
+0.02%
|
-
|
|
Apr 01
2023
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
1,176
+6.15%
|
-
|
|
Apr 01
2023
|
Adam Garrard Head of Risk & Broking |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
4
+0.02%
|
-
|
|
Apr 01
2023
|
Adam Garrard Head of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
2,111
+5.52%
|
-
|
|
Apr 01
2023
|
Matthew Furman General Counsel |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3
+0.01%
|
-
|
|
Apr 01
2023
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
952
+49.51%
|
-
|
|
Apr 01
2023
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
29
+0.04%
|
-
|
|
Apr 01
2023
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,144
+10.91%
|
-
|
|
Apr 01
2023
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
107
+11.24%
|
-
|
|
Apr 01
2023
|
Anne Donovan Bodnar Chief Administrative Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3
+0.03%
|
-
|
|
Apr 01
2023
|
Alexis Faber Chief Operating Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
2
+0.04%
|
-
|
|
Apr 01
2023
|
Alexis Faber Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
773
+13.13%
|
-
|
|
Apr 01
2023
|
Kristy D Banas Chief Human Resources Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
2
+0.05%
|
-
|
|
Apr 01
2023
|
Kristy D Banas Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
766
+16.71%
|
-
|
|
Apr 01
2023
|
Pamela Thomson Hall Head of International |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1
+0.02%
|
-
|
|
Apr 01
2023
|
Pamela Thomson Hall Head of International |
BUY
Grant, award, or other acquisition
|
Direct |
529
+11.63%
|
-
|
|
Apr 01
2023
|
Imran Ahmed Qureshi Head of North America |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3
+0.08%
|
-
|
|
Apr 01
2023
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
1,087
+21.8%
|
-
|
|
Apr 01
2023
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
2,258
+1.32%
|
-
|
|
Apr 01
2023
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
4
+0.0%
|
-
|
|
Apr 01
2023
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
6
+0.05%
|
-
|
|
Apr 01
2023
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,721
+12.35%
|
-
|
|
Apr 01
2023
|
Jacqueline Hunt Director |
BUY
Grant, award, or other acquisition
|
Direct |
143
+50.0%
|
-
|
|
Apr 01
2023
|
Fredric J Tomczyk Director |
BUY
Grant, award, or other acquisition
|
Direct |
143
+50.0%
|
-
|
|
Apr 01
2023
|
Stephen M. Chipman Director |
BUY
Grant, award, or other acquisition
|
Direct |
143
+50.0%
|
-
|
|
Mar 03
2023
|
Matthew Furman General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,080
-22.11%
|
$2,170,120
$239.12 P/Share
|
|
Mar 03
2023
|
Matthew Furman General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,571
+23.44%
|
$1,458,236
$116.68 P/Share
|
|
Mar 01
2023
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
2,500
-1.48%
|
$582,500
$233.35 P/Share
|
|
Feb 14
2023
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
3,000
-1.15%
|
$738,000
$246.62 P/Share
|
|
Feb 09
2023
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.98%
|
$1,265,000
$253.5 P/Share
|
|
Feb 06
2023
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,611
+11.25%
|
-
|
|
Feb 06
2023
|
Alexis Faber Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,075
+19.85%
|
-
|
|
Feb 06
2023
|
Kristy D Banas Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
443
+12.68%
|
-
|
|
Feb 06
2023
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
4,695
+5.06%
|
-
|
|
Feb 06
2023
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
202
-0.31%
|
$50,904
$252.39 P/Share
|
|
Feb 06
2023
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,695
+6.67%
|
-
|
|
Feb 06
2023
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
924
+24.73%
|
-
|
|
Feb 06
2023
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
322
+30.38%
|
-
|
|
Feb 06
2023
|
Adam Garrard Head of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
3,983
+19.5%
|
-
|
|
Feb 06
2023
|
Pamela Thomson Hall Head of International |
BUY
Grant, award, or other acquisition
|
Direct |
645
+15.59%
|
-
|
|
Feb 06
2023
|
Anne Donovan Bodnar Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,437
+19.53%
|
-
|
|
Feb 06
2023
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
3,573
+17.56%
|
-
|
|
Nov 21
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
5,000
-5.66%
|
$1,175,000
$235.07 P/Share
|
|
Nov 18
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Open market or private sale
|
Direct |
8,112
-11.64%
|
$1,906,320
$235.0 P/Share
|